Photos: 

Evaluation reports are either openly accessible via pdf download, or accessible via MSF's internal Sharepoint, which is mainly due to the sensitive nature of the operational contexts and resulting content. However, there are ongoing discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

Topic

Country/Region

C

Through an analysis of the events that have marked MSF’s history since 2003, this series of case studies and historical accounts describes the evolution of MSF's humanitarian ambitions, the resistance to these ambitions and the political arrangements that overcame this resistance (or that failed to do so).

edited by Claire Magone, Michaël Neuman, Fabrice Weissman
22/11/2011

The evaluation looks at the process for managing MSF-OCP's construction/rehabilitation projects since 2012. The main problems identified are not related to the process itself, but the way it is put into application. The main users pointed out the long delays (periods of indicision) as being the biggest difficulty, followed by budget/cost issues (cost/m² estimates) , and the quality of constructions (techniques, materials, etc). One of the root causes of delays relates to unclear/incomplete definition of roles and responsibilities = actions to take.

Nicolas Bérubé & Vincent Brown
16/07/2015

Full version and short version available. This evaluation of the viral load (VL) monitoring system was commissioned in order to more fully understand the experience and outcomes of the introduction and scale-up of VL in one district of Zimbabwe but also undertaken with a view to the national scale-up of VL monitoring, and the general issue of VL monitoring in sub-Saharan Africa in light of the UNAIDS 90-90-90 targets. The report details five clear recommendations to reach undetectable viral load.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Richard Bedell.
21/04/2016

This evaluation has been triggered by the recent finding that a substantial proportion of the Changara project’s patients had a high VL of more than 3,000 copies/ml (the criteria at the time), raising questions on the efficacy of the counselling services. Although the relationship between counselling and high VL remains unclear, this report details three key recommendations aimed at improving the overall efficacy of the counselling services.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Mranda Brouwer of PHTB Consult. This publication was produced at the request of Médécins sans Frontières. It was prepared independently by Miranda Brouwer of PHTB Consult.
21/04/2016

This report summarises the key lessons learned from MSF's cholera interventions in Zambia 2004, 2006, 2008, 2010 (OCBA), Guinea Bissau 2005-2008 (OCBA), Juba 2006 (OCBA), Haiti 2010-2011 (OCBA), Angola 2006 (OCB, OCA, OCBA), Zimbabwe 2009 (OCB, OCA, OCBA)

M Iscla
09/05/2012

Optimizing HIV, TB and NCD treatment in five sub-saharan countries.

This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by Catherine Lalonde and Joost van der Meer.
12/02/2018

RIDER, CRASH and Epicentre have finalized a critical review of the operations of MSF France in Borno, Nigeria, from 2015 to 2016.

***English and French version available***

This publication was produced by RIDER, CRASH and Epicentre.
01/03/2019

The objective of this lessons learnt exercise was to assess the advantages and disadvantages of the UNITAID grant governance and management model for project achievements in terms of medical (and related) outcomes, strategic decisions, the potential for collaboration between multiple MSF entities and to leverage the learnings for replication in future projects. The exercise showed that the project directly delivered a new, more effective, simpler and much cheaper treatment to patients across seven countries.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Hugues Juillerat, Sharon McClenaghan and Glenn O’Neil of TRAASS International.
15/01/2019

Pages